Concurrent chemoradiotherapy (CRT) with high-dose cisplatin is the standard non-surgical treatment for advanced head and neck cancer. However, treatment-related complications such as weight loss and muscle wasting are known prognostic factors that can negatively affect clinical outcomes. This retrospective study evaluated the effectiveness of supportive interventions, including in-hospital physical rehabilitation and the use of Kampo medicines (Rikkunshito and Ninjinyoeito), administered during CRT.
The introduction of rehabilitation led to a statistically significant reduction in weight loss compared to no intervention (
p<0.05). While the change in skeletal muscle index (SMI) did not differ significantly among the groups, there was a trend toward reduced SMI loss in patients who received rehabilitation and Kampo medicines.
Importantly, the incidence of grade ≥3 infectious complications during CRT was significantly lower in the Ninjinyoeito group compared to the other groups (
p=0.007). Neither rehabilitation nor Kampo medicine administration was associated with an increase in other CRT-related adverse events, suggesting that these interventions are safe.
These findings suggest that physical rehabilitation and Kampo medicines may serve as safe and effective supportive therapies during CRT. They appear to help preserve body weight and muscle mass, and may reduce the risk of severe infectious complications, thereby improving treatment tolerance and clinical outcomes in patients undergoing CRT for head and neck cancer.
View full abstract